History of Gene Therapy

Gene therapy is an experimental medical procedureAnother setback to gene therapy occurred in 1999.
that attempts to correct a genetic mutation (missingAn eighteen-year-old patient named Jesse Gelsinger
or changed genes) so that properly functioning geneswas involved in a gene therapy trial for a genetic
are restored to cells. When gene therapy works, thedisease called ornithine transcarboxylase deficiency
correct instructions for building proteins (chemicals(OTCD). This rare disease prevents the liver from
that direct and control chemical reactions in the body)breaking down ammonia, which can build up in the
are once again available to cells, and the body returnsbody and become toxic. Gelsinger died from organ
to normal or healthier function.failure four days after starting treatment.
Scientists first began discussing the possibility of thisResearchers believe his immune system reacted to
method to cure diseases in the 1960s. In 1970,the virus that carried the new gene into his cells.
American doctor Stanfield Rogers at Oak RidgeIn 2000, French researcher Alain Fischer was able to
National Laboratory in Tennessee tried to use genecure children of a similar kind of immune system
therapy to treat two sisters who had a geneticdisorder. Fischer used retroviruses as gene carriers.
disorder called argininemia. With this genetic disorder,Retroviruses are a type of virus that uses ribonucleic
the body lacks an enzyme (a type of protein) calledacid (RNA) as its genetic material, instead of DNA.
arginase. People with this disorder can have seizuresRetroviruses produce an enzyme (a protein that
and mental impairment. Rogers tried to treat thecontrols a biochemical reaction) that builds DNA upon
sisters by using a virus to carry the healthy gene intoa strand of RNA. The most well known of these
their cells. In this case, the gene therapy wasretroviruses is the human immunodeficiency virus
unsuccessful.(HIV), the virus responsible for acquired immune
In 1977, scientists were able to use gene therapydeficiency syndrome (AIDS). Fischer inserted a
techniques to deliver a gene into the cells ofretrovirus carrying the normal gene into the children's
mammals. American doctor W. French Andersonblood stem cells. Several months later, two of the
performed one of the first studies of gene therapychildren in the trial developed a disease similar to
in humans in 1990 on a four-year-old girl who had aleukemia (a type of cancer that starts in the cells
rare genetic immune system disorder called severethat make blood cells). As a result, the U.S. Food and
combined immunodeficiency (SCID). The immuneDrug Administration (FDA) halted the use of
system fights off infections from bacteria andretroviruses in the United States.
viruses, and the disorder made it difficult for herAlthough research in this field has moved slowly, it still
body to stay healthy. Anderson and his teammoved forward. In 2003, the first officially licensed
genetically altered her white blood cells and thengene therapy was available in China. Several types of
returned them to her body. The new white bloodgene therapy are waiting for approval from the U.S.
cells strengthened the girl's immune system and madeFood and Drug Administration.
it possible for her to survive.